Key facts
- This page summarizes Invus Public Equities, L.P.'s Form 4 filing for Omega Therapeutics, Inc. (OMGAQ).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Aug 2021, 17:16.
Invus Public Equities, L.P. - 30 Jul 2021 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OMGAQ
- Reported as of
- 30 Jul 2021
- Net transaction value
- +$16,085,342
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2021, 17:16:05 UTC
- Prior SEC filing
- 29 Jul 2021
- Next SEC filing
- 24 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- Invus Public Equities, L.P., By: Invus Public Equities Advisors, LLC, its General Partner, By: /s/ Raymond Debbane, President
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Invus Public Equities, L.P. filed Form 4 for Omega Therapeutics, Inc. (OMGAQ) on 03 Aug 2021.
Change
- Previous filing in this sequence was filed on 29 Jul 2021.
- Current net transaction value: +$16,085,342.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMGA
transaction
Common Stock
Purchase
- Transaction value
- $1,210,342
- Shares
- +75,000
- Change %
- Price
- $16.14
- Shares after
- 75,000
- Date
- 30 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
OMGA
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,323,530
- Change %
- +1765%
- Price
- Shares after
- 1,398,530
- Date
- 03 Aug 2021
- Ownership
- Direct
- Footnotes
- F2, F3, F4
OMGA
transaction
Common Stock
Purchase
- Transaction value
- $14,875,000
- Shares
- +875,000
- Change %
- +63%
- Price
- $17.00
- Shares after
- 2,273,530
- Date
- 03 Aug 2021
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMGA
transaction
Derivative
Series C Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -5,000,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,323,530
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Invus Public Equities, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
The shares reported as purchased on July 30, 2021 were purchased in several transactions at actual purchase prices ranging from $16.00 to $16.2068 per share, in each case exclusive of any fees, commissions or other expenses. The price reported reflects the weighted average purchase price for the transactions. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Footnote F2
The shares are held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. Artal Treasury Ltd is the managing member of Invus Public Equities Advisors, LLC. Artal Treasury Ltd is a wholly owned subsidiary of the Geneva branch of Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting").
Footnote F3
(Continued from Footnote 2) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Footnote F4
The shares of Issuer's preferred stock had no expiration date and were convertible at the holder's election into Issuer's common stock at a conversion ratio of 1-to-0.264706. The preferred stock automatically converted into shares of the Issuer's common stock, for no additional consideration, upon the closing of the Issuer's initial public offering.